Lumos Diagnostics Holdings Limited LDXHF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.19M | 12.70M | 12.21M | 12.31M | 12.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.19M | 12.70M | 12.21M | 12.31M | 12.40M |
| Cost of Revenue | 5.32M | 4.97M | 4.62M | 4.67M | 4.72M |
| Gross Profit | 7.88M | 7.73M | 7.59M | 7.64M | 7.68M |
| SG&A Expenses | 19.05M | 17.52M | 15.99M | 14.56M | 13.13M |
| Depreciation & Amortization | 2.55M | 2.50M | 2.46M | 2.49M | 2.53M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.32M | 25.32M | 23.33M | 21.90M | 20.47M |
| Operating Income | -14.13M | -12.62M | -11.11M | -9.59M | -8.07M |
| Income Before Tax | -4.95M | -7.11M | -9.26M | -8.22M | -7.18M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.95 | -7.11 | -9.26 | -8.22 | -7.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.95M | -7.11M | -9.26M | -8.22M | -7.18M |
| EBIT | -14.13M | -12.62M | -11.11M | -9.59M | -8.07M |
| EBITDA | -12.41M | -10.89M | -9.36M | -7.81M | -6.25M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 3.25B | 3.15B | 3.04B | 2.88B | 2.72B |
| Average Diluted Shares Outstanding | 3.25B | 3.15B | 3.04B | 2.88B | 2.72B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |